• Home
  • Careers
  • Contact
  • About Us
  • News
  • Investors | Partners
  • Products | Research
Highlights
  • Noah Rosenberg, MD, Joins Esperion Therapeutics as Chief Medical Officer
    April 8, 2012
  • Esperion announces positive phase 2 clinical trial results for ETC-1002
    March 25, 2012
  • Esperion announces results from Phase 1 study and four preclinical studies for ETC-1002
    May 2, 2011
 
Home     Careers     Contact   Site Map Privacy Policy Terms of Use Copyright © 2011 Esperion Therapeutics, Inc. All rights reserved.